{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:28:00Z","timestamp":1778894880075,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.sleep.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T03:13:26Z","timestamp":1584760406000},"page":"48-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-6488","authenticated-orcid":false,"given":"Agata","family":"Gabryelska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Szmyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L.","family":"Maschauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Roguski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Canham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Bia\u0142asiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8983-9985","authenticated-orcid":false,"given":"Renata L.","family":"Riha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2020.03.009_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/practneurol-2014-000837","article-title":"Narcolepsy: a clinical review","volume":"14","author":"Leschziner","year":"2014","journal-title":"Pract Neurol"},{"key":"10.1016\/j.sleep.2020.03.009_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.14-1304","article-title":"Central disorders of hypersomnolence: focus on the narcolepsies and idiopathic hypersomnia","volume":"148","author":"Khan","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2020.03.009_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/13543784.2018.1459561","article-title":"An overview of hypocretin based therapy in narcolepsy","volume":"27","author":"Takenoshita","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.sleep.2020.03.009_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","article-title":"Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test","volume":"28","author":"Littner","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2020.03.009_bib5","first-page":"93","article-title":"Diagnostic lumbar puncture","volume":"83","author":"Doherty","year":"2014","journal-title":"Ulster Med J"},{"key":"10.1016\/j.sleep.2020.03.009_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neures.2017.03.015","article-title":"The roles of orexins in sleep\/wake regulation","volume":"118","author":"Mieda","year":"2017","journal-title":"Neurosci Res"},{"key":"10.1016\/j.sleep.2020.03.009_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2006.10.019","article-title":"Orexin and psychiatric symptoms in suicide attempters","volume":"100","author":"Brundin","year":"2007","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.sleep.2020.03.009_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-013-0064-z","article-title":"Role of orexin in the pathophysiology of depression: potential for pharmacological intervention","volume":"27","author":"Nollet","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2020.03.009_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/014107680209500503","article-title":"The hypocretin\/orexin system","volume":"95","author":"Ebrahim","year":"2002","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.sleep.2020.03.009_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.psychres.2011.06.004","article-title":"CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls","volume":"190","author":"Schmidt","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.sleep.2020.03.009_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.sleep.2020.03.009_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/sleep\/33.2.169","article-title":"Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population","volume":"33","author":"Knudsen","year":"2010","journal-title":"Sleep"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945720301210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945720301210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:21:17Z","timestamp":1761405677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945720301210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":12,"alternative-id":["S1389945720301210"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2020.03.009","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}